{"entity":{"type":"insider","cik":"0001900772","url":"/insider/0001900772","json_url":"/insider/0001900772.json","name":"Burns James William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":12,"first":"2023-06-30","last":"2026-04-06","span_basis":"filed_date"},"name_variants":[{"name":"Burns James William","source":"filing","n_filings":12,"first_seen":"2023-06-30","last_seen":"2026-04-06"}],"transactions":[{"id":5946629,"accession":"0001439222-26-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000067","line_url":"/filing/0001439222-26-000067#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3280.0,"shares_display":"3,280","price_per_share":34.71,"price_display":"34.71","price_state":"stated","total_value":113848.8,"total_display":"113,848.80","shares_owned_after":49306.0,"shares_owned_after_display":"49,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider"},{"id":5946625,"accession":"0001439222-26-000042","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001439222-26-000042","line_url":"/filing/0001439222-26-000042#line-8","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1681.0,"shares_display":"1,681","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":48681.76,"total_display":"48,681.76","shares_owned_after":38516.0,"shares_owned_after_display":"38,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5946623,"accession":"0001439222-26-000042","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001439222-26-000042","line_url":"/filing/0001439222-26-000042#line-7","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1187.0,"shares_display":"1,187","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":34375.52,"total_display":"34,375.52","shares_owned_after":41329.0,"shares_owned_after_display":"41,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5946622,"accession":"0001439222-26-000042","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-26-000042","line_url":"/filing/0001439222-26-000042#line-6","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1187.0,"shares_display":"1,187","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":34375.52,"total_display":"34,375.52","shares_owned_after":34531.0,"shares_owned_after_display":"34,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5946620,"accession":"0001439222-26-000042","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001439222-26-000042","line_url":"/filing/0001439222-26-000042#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1163.0,"shares_display":"1,163","price_per_share":28.96,"price_display":"28.96","price_state":"stated","total_value":33680.48,"total_display":"33,680.48","shares_owned_after":44086.0,"shares_owned_after_display":"44,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5777405,"accession":"0001439222-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-26-000010","line_url":"/filing/0001439222-26-000010#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2932.0,"shares_display":"2,932","price_per_share":27.09,"price_display":"27.09","price_state":"stated","total_value":79427.88,"total_display":"79,427.88","shares_owned_after":31718.0,"shares_owned_after_display":"31,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-30","filed_date":"2026-01-02","scope":"insider"},{"id":5137598,"accession":"0001439222-25-000071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000071","line_url":"/filing/0001439222-25-000071#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2799.0,"shares_display":"2,799","price_per_share":33.54,"price_display":"33.54","price_state":"stated","total_value":93878.46,"total_display":"93,878.46","shares_owned_after":28650.0,"shares_owned_after_display":"28,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":5137592,"accession":"0001439222-25-000021","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001439222-25-000021","line_url":"/filing/0001439222-25-000021#line-6","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1681.0,"shares_display":"1,681","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":59742.74,"total_display":"59,742.74","shares_owned_after":25449.0,"shares_owned_after_display":"25,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":5137588,"accession":"0001439222-25-000021","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001439222-25-000021","line_url":"/filing/0001439222-25-000021#line-5","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1187.0,"shares_display":"1,187","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":42185.98,"total_display":"42,185.98","shares_owned_after":21463.0,"shares_owned_after_display":"21,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":5137584,"accession":"0001439222-25-000021","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-25-000021","line_url":"/filing/0001439222-25-000021#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1137.0,"shares_display":"1,137","price_per_share":35.54,"price_display":"35.54","price_state":"stated","total_value":40408.98,"total_display":"40,408.98","shares_owned_after":18650.0,"shares_owned_after_display":"18,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":2104219,"accession":"0001439222-24-000140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000140","line_url":"/filing/0001439222-24-000140#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13411.0,"shares_display":"13,411","price_per_share":52.0,"price_display":"52.00","price_state":"stated","total_value":697372.0,"total_display":"697,372.00","shares_owned_after":24041.0,"shares_owned_after_display":"24,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-12","scope":"insider"},{"id":2104215,"accession":"0001439222-24-000140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-24-000140","line_url":"/filing/0001439222-24-000140#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8341.0,"shares_display":"8,341","price_per_share":52.56,"price_display":"52.56","price_state":"stated","total_value":438402.96,"total_display":"438,402.96","shares_owned_after":15700.0,"shares_owned_after_display":"15,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-12","scope":"insider"},{"id":2111623,"accession":"0001439222-24-000046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001439222-24-000046","line_url":"/filing/0001439222-24-000046#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1349.0,"shares_display":"1,349","price_per_share":32.57,"price_display":"32.57","price_state":"stated","total_value":43936.93,"total_display":"43,936.93","shares_owned_after":37169.0,"shares_owned_after_display":"37,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider"},{"id":2111621,"accession":"0001439222-24-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001439222-24-000046","line_url":"/filing/0001439222-24-000046#line-3","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1293.0,"shares_display":"1,293","price_per_share":32.57,"price_display":"32.57","price_state":"stated","total_value":42113.01,"total_display":"42,113.01","shares_owned_after":34518.0,"shares_owned_after_display":"34,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-05","scope":"insider"},{"id":3003135,"accession":"0001439222-24-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000028","line_url":"/filing/0001439222-24-000028#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":545.0,"shares_display":"545","price_per_share":25.14,"price_display":"25.14","price_state":"stated","total_value":13701.3,"total_display":"13,701.30","shares_owned_after":31666.0,"shares_owned_after_display":"31,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-14","filed_date":"2024-02-14","scope":"insider"},{"id":2424270,"accession":"0001439222-24-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000022","line_url":"/filing/0001439222-24-000022#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1708.0,"shares_display":"1,708","price_per_share":21.64,"price_display":"21.64","price_state":"stated","total_value":36961.12,"total_display":"36,961.12","shares_owned_after":30378.0,"shares_owned_after_display":"30,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-24","scope":"insider"},{"id":3080449,"accession":"0001439222-24-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000006","line_url":"/filing/0001439222-24-000006#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1163.0,"shares_display":"1,163","price_per_share":22.99,"price_display":"22.99","price_state":"stated","total_value":26737.37,"total_display":"26,737.37","shares_owned_after":26336.0,"shares_owned_after_display":"26,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-09","scope":"insider"},{"id":8632082,"accession":"0001439222-23-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001439222-23-000131","line_url":"/filing/0001439222-23-000131#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6395.0,"shares_display":"6,395","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":168060.6,"total_display":"168,060.60","shares_owned_after":23890.0,"shares_owned_after_display":"23,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-21","scope":"insider"},{"id":7931320,"accession":"0001439222-23-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-23-000109","line_url":"/filing/0001439222-23-000109#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001900772","owner_name":"Burns James William","owner_url":"/insider/0001900772","role":"Officer (Chief Legal Officer)","officer_title":"Chief Legal Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1707.0,"shares_display":"1,707","price_per_share":28.36,"price_display":"28.36","price_state":"stated","total_value":48410.52,"total_display":"48,410.52","shares_owned_after":30285.0,"shares_owned_after_display":"30,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Officer (Chief Legal Officer)","n_filings":12,"first_seen":"2023-06-30","last_seen":"2026-04-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001900772","retrieved_at":"2026-08-21T18:39:32+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}